Dr Sulaiman Al Habib Medical Group reports FY25 results in line with estimates
Dr Sulaiman Al Habib Medical Group reports FY25 results in line with estimates
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Coinbase, Robinhood and Circle are expanding into stablecoins, payments and prediction markets, but their latest earnings show how hard it is to escape cry...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Dr Sulaiman Al Habib Medical Group reports FY25 results in line with estimates
While this fourth-quarter purchase might seem like cause for celebration, investors would be wise to temper their expectations.
If you are wondering whether Microsoft is still attractive at current levels or if the recent pullback has opened a better entry point, this article will h...
The company's vision of the transportation market is revolutionary, and the company is betting big on it.
One fund manager with a global mandate is significantly underweight U.S. assets in favor of the opportunities created in Europe by the reshaping of militar...
Bill Ackman has nearly a quarter of his portfolio split between Amazon and Meta Platforms.
European shares edge higher, buoyed by financials
From OpenAI to Google, India hosts global AI summit
Semiconductors are the foundation upon which technology is built, and this company is ringing the cash register.
Magna International (TSX:MG) reported strong fourth quarter and full year 2025 earnings with a third consecutive year of margin expansion. The company anno...
SkinBioTherapeutics ex-CEO probe triggers revenue cut, fraud allegations
SkinBioTherapeutics slashes revenue amid former CEO misconduct probe